Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 17 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
15 Nov 2022
Director
Bought
200
$14.94K
6.4%
14 Nov 2022
Director
Bought
200
$15.26K
6.8%
10 Nov 2022
Director
Bought
150
$11.96K
5.4%
7 Nov 2022
CEO, Medical Segment
Sold, plan not stated
61,216
$4.95M
55.5%
7 Nov 2022
Chief Human Resources Officer
Sold, plan not stated
19,590
$1.55M
38.6%
18 Nov 2021
Chief Human Resources Officer
Sold, plan not stated
10,000
$491.70K
21.3%
26 Feb 2021
Chief Legal/Compliance Officer
Sold, plan not stated
3,500
$180.36K
21.7%
11 Feb 2021
Chief Accounting Officer
Sold, plan not stated
3,291
$171.07K
35.1%
13 Nov 2018
SVP & Chief Accounting Officer
Sold, plan not stated
46
$2.58K
0.7%
12 Nov 2018
SVP & Chief Accounting Officer
Sold, plan not stated
758
$42.08K
10.7%
20 Aug 2018
CEO, Medical Segment
Sold, plan not stated
2,890
$150.14K
3.8%
20 Feb 2018
CEO, Medical Segment
Sold, plan not stated
7,995
$549.92K
12.7%
14 Feb 2018
Chief Information Officer
Sold, plan not stated
28,532
$1.89M
44.1%
22 Jan 2018
Chief Executive Officer
Sold, plan not stated
18,586
$1.37M
8.1%
12 May 2017
CEO, Pharmaceutical Segment
Sold, plan not stated
23,270
$1.70M
42.0%
10 Feb 2017
Chairman and CEO
Sold, plan not stated
217,994
$16.84M
32.0%
10 Nov 2016
Chairman and CEO
Sold, plan not stated
217,995
$15.54M
32.0%
Showing 1–17 of 17.